首页> PloS one> Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.

Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.

导出 OA

翻译打印收藏纠错

第一作者： Johannes C,van der Mijn

第一单位： Department of Pharmacology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.;Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

作者： Johannes C,van der Mijn ^[1] ; Bashir,Al Hussein Al Awamlh ^[2] ; Aleem,Islam Khan ^[2] ; Lina,Posada-Calderon ^[2] ; Clara,Oromendia ^[3] ; Jonathan,Fainberg ^[2] ; Mark,Alshak ^[2] ; Rahmi,Elahjji ^[2] ; Hudson,Pierce ^[2] ; Benjamin,Taylor ^[2] ; Lorraine J,Gudas ^[4] ; David M,Nanus ^[5] ; Ana M,Molina ^[5] ; Joseph,Del Pizzo ^[2] ; Douglas S,Scherr ^[2]

作者单位： Department of Pharmacology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America.;Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands. ^[1] Department of Urology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America. ^[2] Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America. ^[3] Department of Pharmacology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America. ^[4] Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, United States of America. ^[5]